SeqLL Inc (SQL)

You never read any filings and here are the facts.
I suspected he was pushed out, and the SEC filings completely validate that.
?Castellum (NYSE-American: CTM) filed an 8-K stating that Wright "resigned" effective December 31, 2025. While corporate PR always uses the standard "no disp

The OTCM data is messed up. The ~149M unrestricted common shares were posted on December 9/25 and the 20M restricted common shares were posted Feb 25/26. No share issuance has occured since.

The exception being the 200M for the Kendrick deal, due to close within the next 3 weeks and s

You know your technology, no question about it.

Very clear

"He would be way too young for that."
Dude ... dude ... George was 66 years old. That is nott "way too young to die".

CANCER CHARLIE was 60 when he stopped circulating hemoglobin-containing envelopes, and he lived seven (7) years after diagnosis. His widowed wife is 61 and has

AI Overview 👉️ Yes, Malikie keeps its first $200 million in gross recoveries, and BlackBerry (BB) only begins receiving a percentage of the profits after Malikie is "made whole".

What date did these 4 settlements happen?

AI

The sentiment around AVXL seems extremely negative right now, which is often when biotech stocks become the most interesting to watch. There are still plenty of unanswered questions, but I think the next meaningful update from management will be more important than the daily share price fluctuations

The changes look good, but are simply cosmetic. It’s still the same app it was before. Still waiting for the most basic problems to be fixed. I guess we’ll just have to wait and see. Hope he comes through and something good happens. Best to all,WW

Oh Hell Yes something is brewing alright, Let’s all hold hands and pray for news$$$

i called it would break 30mil short, now it looks like they want 40mil.......anything really significant comes out and this will sky rocket!!!

You also forgot to mention that it is highly speculated that Talisman Group (hedge fund) created and used SPV to acquire more than the 71% of TGLO that delfin already owns. Which leads everyone to believe the float is much smaller than it appears on the surface 

⏰️🐎🐎🐎 How has a recent Supreme Court ruling shifted SEC disgorgement powers in a bankruptcy case? The June 2026 Supreme Court ruling as it relates to LBHI's bankruptcy.

The U.S. Supreme Court did not rule on a case combining both Securities and Exchange Commiss

Not gonna lie. I have mixed emotions about this haha

WHY DOES IT NOT LOOK LIKE WINNING ?

You can’t do anything to stop someone from using your patents until they have a product introduced into the marketplace. You have to prove infringement of patents regarding material structure, manufacture or usage. You can’t do that until a finished product is sold and used by a customer. Usually a

It’s been violated since the Net Worth Sweep.

Less than a month ago we were in the trips..so we have had traction.
Looks like it basing here for next leg up.

Only thing suppressing trades is the lack of investors. Wake up.

Hera gives the FHFA one mission as conservator, and that is preserved and conserv and make solvent. Once that is completed the FHFA director‘s job is complete and the company should be released The companies are no longer independent and insulated from the president political reasoning if they have

Completely agree on the intrinsic. Waiting game simply gets old. Few weeks away from next cc. 

someone posted "Rich" might chime in

I KNOW WHAT I OWN, A chance for a grand slam home run from a little stinky pinky mining stock about to explode

anxiously awaiting the next news release

Which chrome Microsoft  chrome 🤣? Ahh you think your words are useful lmaoo . BCAP LETS MAKE HISTORY 📈💥💨

“You realize we’ve dropped like 20% on what equates to 0.0005% of total shares per trading sessions.”

Bingo. What I’ve also been thinking about today is this - we just got acceptance of the ANDA filing for Eliquis. The price jumped after the announcement on slightly more volume but ha

Gsk retained some R and D in oncology and notably retained what became belantamab. I wonder if GSK gets back into oncology if belantamab didn’t show such promise (yet to be realized commercially). I feel like they bought tesaro to get some critical mass in oncology bc having just one drug launch is

Customers Bank... so close but so far away.